Literature DB >> 21248029

A herpesvirus virulence factor inhibits dendritic cell maturation through protein phosphatase 1 and Ikappa B kinase.

Huali Jin1, Zhipeng Yan, Yijie Ma, Youjia Cao, Bin He.   

Abstract

Dendritic cells are sentinels in innate and adaptive immunity. Upon virus infection, a complex program is in operation, which activates IκB kinase (IKK), a key regulator of inflammatory cytokines and costimulatory molecules. Here we show that the γ(1)34.5 protein, a virulence factor of herpes simplex viruses, blocks Toll-like receptor-mediated dendritic cell maturation. While the wild-type virus inhibits the induction of major histocompatibility complex (MHC) class II, CD86, interleukin-6 (IL-6), and IL-12, the γ(1)34.5-null mutant does not. Notably, γ(1)34.5 works in the absence of any other viral proteins. When expressed in mammalian cells, including dendritic cells, γ(1)34.5 associates with IKKα/β and inhibits NF-κB activation. This is mirrored by the inhibition of IKKα/β phosphorylation, p65/RelA phosphorylation, and nuclear translocation in response to lipopolysaccharide or poly(I:C) stimulation. Importantly, γ(1)34.5 recruits both IKKα/β and protein phosphatase 1, forming a complex that dephosphorylates two serine residues within the catalytic domains of IκB kinase. The amino-terminal domain of γ(1)34.5 interacts with IKKα/β, whereas the carboxyl-terminal domain binds to protein phosphatase 1. Deletions or mutations in either domain abolish the activity of γ(1)34.5. These results suggest that the control of IκB kinase dephosphorylation by γ(1)34.5 represents a critical viral mechanism to disrupt dendritic cell functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248029      PMCID: PMC3067875          DOI: 10.1128/JVI.02373-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy.

Authors:  Laila Samady; Emanuela Costigliola; Luci MacCormac; Yvonne McGrath; Steve Cleverley; Caroline E Lilley; Jill Smith; David S Latchman; Benny Chain; Robert S Coffin
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection.

Authors:  Huali Jin; Yijie Ma; Bellur S Prabhakar; Zongdi Feng; Tibor Valyi-Nagy; Zhipeng Yan; Dustin Verpooten; Cuizhu Zhang; Youjia Cao; Bin He
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

3.  Inhibition of dendritic cell maturation by herpes simplex virus.

Authors:  M Salio; M Cella; M Suter; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

Review 4.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

5.  Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1.

Authors:  Z Mikloska; L Bosnjak; A L Cunningham
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses.

Authors:  Carolina B López; Adolfo García-Sastre; Bryan R G Williams; Thomas M Moran
Journal:  J Infect Dis       Date:  2003-03-19       Impact factor: 5.226

7.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

8.  The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells.

Authors:  Christopher R Cotter; Marie L Nguyen; Jacob S Yount; Carolina B López; John A Blaho; Thomas M Moran
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity.

Authors:  Gabriele Pollara; Katharina Speidel; Laila Samady; Mansi Rajpopat; Yvonne McGrath; Jonathan Ledermann; Robert S Coffin; David R Katz; Benjamin Chain
Journal:  J Infect Dis       Date:  2003-01-06       Impact factor: 5.226

10.  Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.

Authors:  Xinyan Zhao; Eszter Deak; Kelly Soderberg; Melissa Linehan; David Spezzano; Jia Zhu; David M Knipe; Akiko Iwasaki
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  18 in total

1.  Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.

Authors:  Huali Jin; Yijie Ma; Zhipeng Yan; Bellur S Prabhakar; Bin He
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Authors:  Christopher R Cotter; Won-keun Kim; Marie L Nguyen; Jacob S Yount; Carolina B López; John A Blaho; Thomas M Moran
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein.

Authors:  Yin Yang; Songfang Wu; Yu Wang; Shuang Pan; Bei Lan; Yaohui Liu; Liming Zhang; Qianli Leng; Da Chen; Cuizhu Zhang; Bin He; Youjia Cao
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

4.  Selective Editing of Herpes Simplex Virus 1 Enables Interferon Induction and Viral Replication That Destroy Malignant Cells.

Authors:  Xing Liu; Bin He
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

5.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

6.  2C Proteins of Enteroviruses Suppress IKKβ Phosphorylation by Recruiting Protein Phosphatase 1.

Authors:  Qian Li; Zhenhua Zheng; Yan Liu; Zhenfeng Zhang; Qingshi Liu; Jin Meng; Xianliang Ke; Qinxue Hu; Hanzhong Wang
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

7.  Curcumin inhibits Rift Valley fever virus replication in human cells.

Authors:  Aarthi Narayanan; Kylene Kehn-Hall; Svetlana Senina; Lindsay Lundberg; Rachel Van Duyne; Irene Guendel; Ravi Das; Alan Baer; Laura Bethel; Michael Turell; Amy Lynn Hartman; Bhaskar Das; Charles Bailey; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

8.  Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Authors:  Thessicar E Antoine; Yogendra K Mishra; James Trigilio; Vaibhav Tiwari; Rainer Adelung; Deepak Shukla
Journal:  Antiviral Res       Date:  2012-10-06       Impact factor: 5.970

Review 9.  Recognition of herpes simplex viruses: toll-like receptors and beyond.

Authors:  Yijie Ma; Bin He
Journal:  J Mol Biol       Date:  2013-11-19       Impact factor: 5.469

10.  Herpes Simplex Virus 1 γ134.5 Protein Inhibits STING Activation That Restricts Viral Replication.

Authors:  Shuang Pan; Xing Liu; Yijie Ma; Youjia Cao; Bin He
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.